The membrane phenotype of hairy cell leukemia: a study with monoclonal antibodies
Melo, J.V.; San Miguel, J.F.; Moss, V.E.; Catovsky, D.
Seminars in Oncology 11(4): 381-385
1984
ISSN/ISBN: 0093-7754 PMID: 6334365 Document Number: 236045
Document emailed within 1 workday
Related Documents
Airò, P.; Rossi, G.; Facchetti, F.; Marocolo, D.; Garza, L.; Lanfranchi, A.; Prati, E.; Brugnoni, D.; Malacarne, F.; Cattaneo, R. 1995: Monoclonal expansion of large granular lymphocytes with a CD4+ CD8dim+/- phenotype associated with hairy cell leukemia Haematologica 80(2): 146-149Lauria, F.; Lenoci, M.; Annino, L.; Raspadori, D.; Marotta, G.; Bocchia, M.; Forconi, F.; Gentili, S.; La Manda, M.; Marconcini, S.; Tozzi, M.; Baldini, L.; Zinzani, P.L.; Foà, R. 2001: Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia Haematologica 86(10): 1046-1050
Sugimoto, T.; Tatsumi, E.; Kemshead, J.T.; Helson, L.; Green, A.A.; Minowada, J. 1984: Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies Journal of the National Cancer Institute 73(1): 51-57
Polliack, A.; Leizerowitz, R.; Gazitt, Y. 1987: Phorbol esters and hairy cell leukemia: effects on cell morphology and surface membrane features and comparison with other B cell leukemias Leukemia 1(4): 311-315
Furusawa, S. 1976: Hairy cell leukemia of B-lymphocyte nature: demonstration of monoclonal surface IgG Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 39(5): 767-769
Gómez Morales, M.; De Andrés, M.A.; Garrido, M.L.; Delgado, C.; Cabrera, A.; Garrido, F. 1985: Abnormal phenotype of a chronic lymphatic leukemia: presence of T and B markers defined by monoclonal antibodies Sangre 30(3): 348-354
Koubek, K. 1990: Immunologic classification of lymphoid cells based on the detection of membrane phenotype using monoclonal antibodies in patients with T-lymphoproliferative diseases Vnitrni Lekarstvi 36(8): 746-752
Sgarabotto, D.; Zerbinati, P.; Vianello, F.; Valeri, P.; Girolami, A.; Dazzi, F. 1992: Alpha-interferon treatment of hairy cell leukemia and associated monoclonal large granular lymphocyte proliferation Haematologica 77(4): 367-368
Dĕdic, K.; Zák, P. 2003: Immunohistochemical detection and quantification of minimal residual disease using DBA.44 antibodies in trephination biopsies of hairy cell leukemia Ceskoslovenska Patologie 39(4): 175-177
Böttger, V.; Hering, S.; Jantscheff, P.; Micheel, B. 1985: Monoclonal antibodies against the human leukemia cell line K 562 Archiv für Geschwulstforschung 55(1): 1-8
Seon, B.K. 1984: Specific killing of human T-leukemia cells by immunotoxins prepared with ricin a chain and monoclonal anti-human T-cell leukemia antibodies Cancer Research 44(1): 259-264
Ziegler-Heitbrock, H.W.; Munker, R.; Dörken, B.; Gaedicke, G.; Thiel, E. 1986: Induction of features characteristic of hairy cell leukemia in chronic lymphocytic leukemia and prolymphocytic leukemia cells Cancer Research 46(4 Pt 2): 2172-2178
Copeland, A.R.; Bueso-Ramos, C.; Liu, F.J.; Kornblau, S.M.; Huh, Y.O.; Albitar, M. 1997: Molecular study of hairy cell leukemia variant with biclonal paraproteinemia Archives of Pathology and Laboratory Medicine 121(2): 150-154
Zinzani, P.L.; Lauria, F.; Buzzi, M.; Raspadori, D.; Gugliotta, L.; Bocchia, M.; Macchi, S.; Algeri, R.; Tura, S. 1990: Hairy cell leukemia variant: a morphologic, immunologic and clinical study of 7 cases Haematologica 75(1): 54-57
Poláková, K.; Chorváth, B.; Sedlák, J.; Duraj, J.; Matoska, J.; Karpatová, M. 1985: Monoclonal antibodies against MHC class Ii antigens elicited with a human non-T, non-B acute lymphoblastic leukemia cell line Neoplasma 32(6): 641-648
Molica, S.; Dattilo, A.; Mannella, A. 1995: ICAM-1 expression in B cell chronic lymphocytic leukemia. Analysis of results obtained with 11 different CD54-specific monoclonal antibodies Leukemia 9(5): 934-935
Flandrin, G.; Daniel, M.T.; Fourcade, M.; Chelloul, N. 1973: Hairy cell leukemia (tricholeukocyte leukemia). Clinical and cytological Nouvelle Revue Francaise d'Hematologie 13(5): 609-640
Sperb, R.A.; von Rohr, A.; Ratschiller, D.; Bacchi, M.; Tichelli, A.; Hess, U.; Cerny, T.; Tobler, A.; Betticher, D.C. 1998: 2-CDA in treatment of hairy cell leukemia: a comparison between intravenous and subcutaneous administration. Swiss Study Group of Applied Cancer Research Schweizerische Medizinische Wochenschrift 128(42): 1593-1597
Grant, C.K.; Essex, M.; Pedersen, N.C.; Hardy, W.D.; Stephenson, J.R.; Cotter, S.M.; Theilen, G.H. 1978: Lysis of feline lymphoma cells by complement-dependent antibodies in feline leukemia virus contact cats. Correlation of lysis and antibodies to feline oncornavirus-associated cell membrane antigen Journal of the National Cancer Institute 60(1): 161-166
Schwarzinger, I.; Bettelheim, P.; Chott, A.; Herold, C.; Hinterberger, W.; Köller, U.; Kos, M.; Neumann, E.; Radaszkiewicz, T.; Lechner, K. 1988: Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients Wiener Klinische Wochenschrift 100(2): 47-51